New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Novo Nordisk A/S

NVO

Healthcare Drug Manufacturers General

Novo Nordisk A/S’s revenue for fiscal 2025 (year ended December 2025) was $46.8 billion, up 11.1% from fiscal 2024.

Revenue
+3.87%
EPS
−17.1%
Free cash flow
−14.8%
Total debt
+30.7%

Quarter to September 2026, against a year earlier

38.51 0.38 −0.98%
Market cap
$128.6B
P/E
9.8×
Fwd P/E FY26e
—
Dividend yield
4.62%
F-score
5/9
ROIC
29.6%
Net debt / EBITDA
0.7×
Payout ratio
0.5×

Revenue to profit Twelve months to Sep 30, 2026

Of every $100 of revenue, $32.68 was left as profit. What is an income statement?

Revenue to profit, in billions of dollars and as a share of revenue
Revenue51.9100.0%
Cost of revenue−9.9−19.1%
Gross profit42.080.9%
Research & development−9.7−18.6%
Selling, general & admin−9.8−18.9%
Other operating costs−0.4−0.7%
Operating income22.142.7%
Other income, net+0.50.9%
Income tax−4.9−9.5%
Other items−0.7−1.4%
Net income17.032.7%
RevenueOperating incomeNet incomeNet margin (right axis)
Revenue, operating income and net income, four quarters
Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Revenue$46.8B$50.9B$51.5B$51.9B
Operating income$19.3B$23.2B$22.3B$22.1B
Net income$15.5B$19.0B$17.9B$17.0B
Net margin (right axis)33.1%37.3%34.8%32.7%
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
Revenue
51,914.26 51,459.47 50,936.69 46,792.29

+8 more TTM periods

Gross Profit
41,991.49 41,541.43 41,725.53 37,891.78
Operating Income
22,148.38 22,313.29 23,190.19 19,327.42
EBT
22,619.42 23,314.54 24,274.53 19,763.76
Income after Tax
17,695.64 18,250.62 19,015.84 15,508.51
Net Income Common
17,695.64 18,250.62 19,015.84 15,508.51
EPS (Diluted)
3.97 4.09 4.26 3.47
Shares (Diluted, Weighted)
4,437.37 4,444.67 4,447.39 4,446.64
Gross Margin
80.89% 80.73% 81.92% 80.98%
EBIT Margin
42.66% 43.36% 45.53% 41.30%
Net Profit Margin
34.09% 35.47% 37.33% 33.14%
Free Cash Flow Margin
13.25% 14.79% 9.55% 9.38%
EBITDA
27,249.73 26,477.23 26,531.59 22,655.50
EBIT
22,148.38 22,313.29 23,190.19 19,327.42

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026